Halo Announces Proposed Acquisition of Nasalbinoid Natural Devices
TORONTO: Halo Labs Inc. has entered into a definitive agreement to acquire all of the common shares of Nasalbinoid Natural Devices Corp. for C$5.1 million in Halo common shares at a deemed price of C$0.15 per share (a total of 34 million shares). The common shares issued by Halo in… Continue reading